In these complicated years

[nurmohammadkhan]

The pharmaceutical sector has found itself and is facing unprecedented challenges , and doing so on the front lines. First, the management of the hectic phases of the health emergency triggered by the Covid-19 pandemic in which we found ourselves reacting in a scenario never seen before, with absolute rapidity. An enormous stress that has involved all levels and branches of this sector , from large pharmaceutical companies, to the distribution chain, to international and national regulators, up to individual neighborhood and provincial pharmacies. The supply chain has resisted the shock admirably: today we can say this with awareness. However, be careful: the actors and operators of the sector must not make the mistake of limiting themselves to emergency management .

In this long and complex period, in fact, some trends have emerged armenia whatsapp resource that clearly indicate the direction of a new normality. And new approaches, new operational tools and a new mindset have increasingly taken hold that are here to stay and consolidate more and more. To put it in a slogan: new opportunities born from an unprecedented global crisis. So: what is the primary engine from which all these changes draw their propulsive thrust? Digital Transformation . And what is the fuel that powers the engine? Data . This is an article dedicated to Big Data in the pharmaceutical sector , with their various applications and multiple advantages. We will proceed in order, starting from the basics.